These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9809519)

  • 1. Is myoblast transplantation effective?
    Partridge T; Lu QL; Morris G; Hoffman E
    Nat Med; 1998 Nov; 4(11):1208-9. PubMed ID: 9809519
    [No Abstract]   [Full Text] [Related]  

  • 2. Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
    Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R
    N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dystrophin gene expression in patients with Duchenne muscular dystrophy after myoblast transplantation].
    Shishkin SS; Terekhov SM; Krokhina TB; Shakhovskaia NI; Podobedova AN; Linnaia GF; Tarasov VI; Ovchinnikov VI; Krakhmaleva IN; Zakharov SF; Ershova ES; Limborskaia SA; Pogoda TV; Zotikov EA; Kut'ina RM; Tarksh MA; Sukhorukov VS; Gerasimova NL
    Genetika; 2001 Aug; 37(8):1104-11. PubMed ID: 11642111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene.
    Nakamura A; Yoshida K; Fukushima K; Ueda H; Urasawa N; Koyama J; Yazaki Y; Yazaki M; Sakai T; Haruta S; Takeda S; Ikeda S
    J Clin Neurosci; 2008 Jul; 15(7):757-63. PubMed ID: 18261911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophin and muscular dystrophy: past, present, and future.
    O'Brien KF; Kunkel LM
    Mol Genet Metab; 2001; 74(1-2):75-88. PubMed ID: 11592805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study.
    Miller RG; Sharma KR; Pavlath GK; Gussoni E; Mynhier M; Lanctot AM; Greco CM; Steinman L; Blau HM
    Muscle Nerve; 1997 Apr; 20(4):469-78. PubMed ID: 9121505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pseudometabolic distrophinopathy without immunohistochemical anomaly].
    Serratrice J; Chabrol B; Attarrian S; Figarella-Branger D
    Rev Neurol (Paris); 2000 Feb; 156(2):175-8. PubMed ID: 10743018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystrophin, its gene, and the dystrophinopathies.
    Roberts RG
    Adv Genet; 1995; 33():177-231. PubMed ID: 7484453
    [No Abstract]   [Full Text] [Related]  

  • 9. PGD for dystrophin gene deletions using fluorescence in situ hybridization.
    Malmgren H; White I; Johansson S; Levkov L; Iwarsson E; Fridström M; Blennow E
    Mol Hum Reprod; 2006 May; 12(5):353-6. PubMed ID: 16608904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cloning and sequencing of the junction fragment of dystrophin gene with exons 3 to 5 deletion].
    Zhong M; Pan SY; Lu BX; Jiang L; Li W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):757-9. PubMed ID: 16793593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for muscular disease.
    Johnston N
    Drug Discov Today; 2004 Sep; 9(18):777. PubMed ID: 15364061
    [No Abstract]   [Full Text] [Related]  

  • 12. [Family study allows more optimistic prognosis and genetic counselling in a child with a deletion of exons 50-51 of the dystrophin gene].
    Lesca G; Testard H; Streichenberger N; Pelissier JF; Lestra C; Burel E; Jonveaux P; Michel-Calemard L
    Arch Pediatr; 2007 Mar; 14(3):262-5. PubMed ID: 17258443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immobility reduces muscle fiber necrosis in dystrophin deficient muscular dystrophy.
    Kimura S; Ikezawa M; Nomura K; Ito K; Ozasa S; Ueno H; Yoshioka K; Yano S; Yamashita T; Matuskura M; Miike T
    Brain Dev; 2006 Aug; 28(7):473-6. PubMed ID: 16516424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysferlin and the plasma membrane repair in muscular dystrophy.
    Bansal D; Campbell KP
    Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional enhancement of skeletal muscle by gene transfer.
    Gregorevic P; Chamberlain JS
    Phys Med Rehabil Clin N Am; 2005 Nov; 16(4):875-87, vii-viii. PubMed ID: 16214049
    [No Abstract]   [Full Text] [Related]  

  • 16. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
    Sundaram C; Vydehi B; Meena K; Murthy J
    Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Symptomatic carriers of dystrophinopathy with chromosome X inactivation bias].
    Lesca G; Demarquay G; Llense S; Streichenberger N; Petiot P; Michel-Calemard L; Récan D; Vial C; Ollagnon-Roman E
    Rev Neurol (Paris); 2003 Sep; 159(8-9):775-80. PubMed ID: 13679720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transposon-like element in the dystrophin gene.
    Zatz M; Passos-Bueno MR; Vainzof M
    Am J Med Genet; 1993 Jun; 46(5):601-2. PubMed ID: 8391750
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dystrophin and dystrophin-associated proteins. Their evaluation at the neuromuscular pathology laboratory].
    Navarro C
    Rev Neurol; 1999 Jan 16-31; 28(2):154-8. PubMed ID: 10101784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paternal inheritance or a de novo mutation in a Duchenne Muscular Dystrophy pedigree from South India.
    Purushottam M; Murthy AR; Shubha GN; Gayathri N; Nalini A
    J Neurol Sci; 2008 May; 268(1-2):179-82. PubMed ID: 18031759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.